Clinical end point acceptance limit [Study As­sess­ment]

posted by ElMaestro  – Denmark, 2019-04-05 10:51 (1518 d 23:32 ago) – Posting: # 20126
Views: 2,821

Hello to you too, PKS,

❝ Should I conclude bio-equivalence with the values of [-0.2025, 0.076] in clinical end point study. Can I assume it as within the interval of (-0.20, 0.20)


What does your protocol say on exactly that matter?

Pass or fail!
ElMaestro

Complete thread:

UA Flag
Activity
 Admin contact
22,616 posts in 4,740 threads, 1,611 registered users;
17 visitors (1 registered, 16 guests [including 7 identified bots]).
Forum time: 10:24 CEST (Europe/Vienna)

Nerds don’t just happen to dress informally.
They do it too consistently.
Consciously or not, they dress informally
as a prophylactic measure against stupidity.    Paul Graham

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5